Novus Biologicals™ CD69 Antibody (Genefrontier patent anti-CD69) - Humanized, Novus Biologicals™

Human Monoclonal Antibody

Product Code	Brand	Quantity
30046260	Novus Biologicals™ NBP3-28703-100ug	100 μg
30045393	Novus Biologicals™ NBP3-28703-50ug	50 μg
30044514	Novus Biologicals™ NBP3-28703-1mg	1 mg

Description

CD69 Monoclonal antibody specifically detects CD69 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay

Specifications

• Antigen: CD69
• Applications: Flow Cytometry, ELISA, Functional Assay
• Conjugate: Unconjugated
• Host Species: Human
• Research Discipline: Innate Immunity
• Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
• Gene Alias: Activation inducer molecule, activation inducer molecule (AIM/CD69), AIM, BL-AC/P26, CD69 antigen, CD69 antigen (p60, early T-cell activation antigen), CD69 molecule, CLEC2CC-type lectin domain family 2 member C, C-type lectin domain family 2, member C, EA1, early activation antigen CD69, early lymphocyte activation antigen, Early T-cell activation antigen p60, GP32/28, Leukocyte surface antigen Leu-23, MLR-3
• Immunogen: CD69
• Primary or Secondary: Primary
• Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.

• Clone: Genefrontier patent anti-CD69
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Target Species: Human
• Gene Accession No.: Q07108
• Gene ID (Entrez): 969
• Isotype: IgG1
• Purification Method: Protein A purified
• Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.